人Alpha-synuclein多肽
参阅全部 Alpha-synuclein 蛋白酶
> 90 % HPLC.
No
Synthetic
Human
Our Abpromise guarantee covers the use of ab17041 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
应用
Blocking
Liquid
- First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
- If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
- Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
- Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
- Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.
浓度
1 mg 浓度为 1 mg/ml
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Information available upon request.
Alpha synuclein
Alpha-synuclein
Alpha-synuclein, isoform NACP140
alphaSYN
MGC105443
MGC110988
MGC127560
MGC64356
NACP
Non A beta component of AD amyloid
Non A4 component of amyloid
Non A4 component of amyloid precursor
Non-A beta component of AD amyloid
Non-A-beta component of alzheimers disease amyloid , precursor of
Non-A4 component of amyloid precursor
Non-A4 component of amyloid, precursor of
OTTHUMP00000218549
OTTHUMP00000218551
OTTHUMP00000218552
OTTHUMP00000218553
OTTHUMP00000218554
PARK 1
PARK 4
PARK1
PARK4
Parkinson disease (autosomal dominant, Lewy body) 4
Parkinson disease familial 1
SNCA
Snca synuclein
Snca synuclein, alpha (non A4 component of amyloid precursor)
SYN
Synuclein alpha
Synuclein alpha 140
Synuclein, alpha (non A4 component of amyloid precursor)
SYUA_HUMAN
ELISA - Human Alpha-synuclein peptide (ab17041)
ab10789 gave a positive result in ELISA against the immunising peptide (ab17030, blue line). It gave a negative result in ELISA against the non-modified equivalent peptide (ab17041, red line). This indicates that it is specific for the modified peptide. Not yet tested in other applications.